SEARCH RESULTS FOR: (*bitcoin mining software tools馃挷itenthusiasts.com馃挷Crypto*)(31185 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

VISTADENT® OC COMPLETE LATIN AMERICA
DENTSPLY SIRONA ORTHODONTICS INC.
27-311-99L
Not in Commercial Distribution

  • D7462731199L1 ()
27-311-99L

  • CAD/CAM software
VISTADENT® OC COMPLETE UPDATE
DENTSPLY SIRONA ORTHODONTICS INC.
27-310-99U
Not in Commercial Distribution

  • D7462731099U1 ()
27-310-99U

  • CAD/CAM software
VISTADENT® OC CONSULTANT UPDATE
DENTSPLY SIRONA ORTHODONTICS INC.
27-310-70U
Not in Commercial Distribution

  • D7462731070U1 ()
27-310-70U

  • CAD/CAM software
Glidewell Restorative CT Scanner
Prismatik Dentalcraft, Inc
70-1152-CTS0001
In Commercial Distribution

  • D745701152CTS00010 ()
70-1152-CTS0001

  • CAD/CAM software
fastmill.io system (fastdesign.io computer + fastmill.io)
Prismatik Dentalcraft, Inc
70-1181-MIL0016
In Commercial Distribution

  • D745701181MIL00160 ()
70-1181-MIL0016

  • CAD/CAM software
No Description
Imeka Solutions Inc
1
In Commercial Distribution

  • 00754016387111 ()


  • Radiological PACS software
reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives to patients based on the Contingency management system.
PEAR THERAPEUTICS, INC.
1
In Commercial Distribution

  • 10196439000036 ()
N/A

  • Psychological assessment software
reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system.
PEAR THERAPEUTICS, INC.
1
In Commercial Distribution

  • 10196439000029 ()
N/A

  • Psychological assessment software
reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 days) prescriptiononly treatment for patients with Substance Use Disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: increase abstinence from a patient’s substances of abuse during treatment, and increase retention in the outpatient treatment program This configuration of reSET is intended to provide virtual incentives to patients based on the Contingency management system.
PEAR THERAPEUTICS, INC.
1
In Commercial Distribution

  • 10196439000012 ()
N/A

  • Psychological assessment software
reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 days) prescriptiononly treatment for patients with Substance Use Disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: increase abstinence from a patient’s substances of abuse during treatment, and increase retention in the outpatient treatment program. This configuration of reSET is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system.
PEAR THERAPEUTICS, INC.
1
In Commercial Distribution

  • 10196439000005 ()
N/A

  • Psychological assessment software
< 1 ... 403 404 405 406 407 ... 1000 >